Company: ZURA
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-038042
Chunk: 47

Company: Zura Bio Ltd
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 47
---
 to USD using the average exchange rate for the year ended December 31, 2024 of 1 GBP = USD$1.28). • Eligibility to earn a discretionary bonus. • Reimbursement of Dr. Sidhu’s reasonable travel, hotel and entertainment expenses. During 2024, the Sidhu Agreement also provided for certain payments and benefits in connection with a termination of employment, as described below under the heading “Potential Payments Upon Termination or Change in Control.” On April 8, 2024, Dr. Sidhu transitioned from his role as Chief Executive Officer and entered into a settlement agreement with the Company, as described below under the heading “Potential Payments Upon Termination or Change in Control — Someit Sidhu,” and the Sidhu Agreement was terminated. Dr. Sidhu continues to serve as a non-independent director on our Board. Kim Davis On November 22, 2022, the Company entered into an Offer Letter Agreement with Ms. Davis (the “Davis Agreement”), effective as of November 28, 2022. In connection with her executing the Davis Agreement, Ms. Davis received in January 2023 a signing bonus in the amount of $121,250. The terms of the Davis Agreement provide that she is eligible to receive the following compensation and benefits while she is employed with the Company on an at-will basis: • Annual salary equal to $425,000. • Eligibility to earn an annual performance bonus with a target of 40% of her annual salary. On February 27, 2025, Ms. Davis’s title was changed to Chief Operating Officer, Chief Legal Officer and Corporate Secretary and her annual salary was increased to $493,000 with a target bonus opportunity of 40% of her annual base salary, effective January 1, 2025. Kiran Nistala On November 30, 2023, Zura Bio Limited, a company registered in England and Wales (“Zura UK”) entered into a Service Agreement with its Executive Vice President and Chief Medical Officer, Dr. Kiran Nistala (the “Nistala Agreement”). The terms of the Nistala Agreement provide that he is eligible to receive the following compensation and benefits while he is employed by Zura UK: • Annual salary equal to $409,600 (converted from GBP to USD using the average exchange rate for the year ended December 31, 2024 of 1 GBP = USD$1.28). • Eligibility to earn an annual performance bonus with